ADAR1 links R-loop homeostasis to ATR activation in replication stress response
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad839 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Biao Zhang und 19 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry…. Hauptthemen laut MEDLINE: DNA-Binding Proteins, R-Loop Structures. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of China, Haihe Laboratory of Cell Ecosystem Innovation Fund.
Abstract (Originalsprache)
Unscheduled R-loops are a major source of replication stress and DNA damage. R-loop-induced replication defects are sensed and suppressed by ATR kinase, whereas it is not known whether R-loop itself is actively involved in ATR activation and, if so, how this is achieved. Here, we report that the nuclear form of RNA-editing enzyme ADAR1 promotes ATR activation and resolves genome-wide R-loops, a process that requires its double-stranded RNA-binding domains. Mechanistically, ADAR1 interacts with TOPBP1 and facilitates its loading on perturbed replication forks by enhancing the association of TOPBP1 with RAD9 of the 9–1-1 complex. When replication is inhibited, DNA–RNA hybrid competes with TOPBP1 for ADAR1 binding to promote the translocation of ADAR1 from damaged fork to accumulate at R-loop region. There, ADAR1 recruits RNA helicases DHX9 and DDX21 to unwind R-loops, simultaneously allowing TOPBP1 to stimulate ATR more efficiently. Collectively, we propose that the tempo-spatially regulated assembly of ADAR1-nucleated protein complexes link R-loop clearance and ATR activation, while R-loops crosstalk with blocked replication forks by transposing ADAR1 to finetune ATR activity and safeguard the genome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), Key Laboratory of Immune Microenvironment and Disease…
- Tianjin Institutes of Health Science, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tian…
- State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & School of Basic Medicine, Peking Union Medical College, 100006, Beijing, China.
Förderung
- National Natural Science Foundation of China
- Ministry of Science and Technology of China
- Haihe Laboratory of Cell Ecosystem Innovation Fund
- CAMS Initiative for Innovative Medicine
- CAMS Fundamental Research Funds for Central Research Institutes
Zitieren
APA
Zhang, B., Li, Y., Zhang, J., Wang, Y., Liang, C., Lu, T., Zhang, C., Liu, L., Qin, Y., He, J., Zhao, X., Yu, J., Hao, J., Yang, J., Li, M. J., Yao, Z., Ma, S., Cheng, H., Cheng, T., & Shi, L. (2023). ADAR1 links R-loop homeostasis to ATR activation in replication stress response. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad839
Vancouver
Zhang B, Li Y, Zhang J, Wang Y, Liang C, Lu T, et al. ADAR1 links R-loop homeostasis to ATR activation in replication stress response. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad839
BibTeX
@article{Zhang2023,
author = {Zhang, Biao and Li, Yi and Zhang, Jieyou and Wang, Yuejiao and Liang, Can and Lu, Ting and Zhang, Chunyong and Liu, Ling and Qin, Yan and He, Jiahuan and Zhao, Xiangnan and Yu, Jia and Hao, Jihui and Yang, Jie and Li, Mulin Jun and Yao, Zhi and Ma, Shuai and Cheng, Hui and Cheng, Tao and Shi, Lei},
title = {ADAR1 links R-loop homeostasis to ATR activation in replication stress response},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad839}
}
EUVIMED